JPWO2020257221A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020257221A5
JPWO2020257221A5 JP2021574932A JP2021574932A JPWO2020257221A5 JP WO2020257221 A5 JPWO2020257221 A5 JP WO2020257221A5 JP 2021574932 A JP2021574932 A JP 2021574932A JP 2021574932 A JP2021574932 A JP 2021574932A JP WO2020257221 A5 JPWO2020257221 A5 JP WO2020257221A5
Authority
JP
Japan
Prior art keywords
seq
body weight
average body
par1
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021574932A
Other languages
English (en)
Japanese (ja)
Other versions
JP7818405B2 (ja
JP2022536797A (ja
JP2022536797A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/038036 external-priority patent/WO2020257221A1/en
Publication of JP2022536797A publication Critical patent/JP2022536797A/ja
Publication of JPWO2020257221A5 publication Critical patent/JPWO2020257221A5/ja
Publication of JP2022536797A5 publication Critical patent/JP2022536797A5/ja
Priority to JP2025133519A priority Critical patent/JP2025172264A/ja
Application granted granted Critical
Publication of JP7818405B2 publication Critical patent/JP7818405B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021574932A 2019-06-18 2020-06-17 炎症性状態を処置するための方法および組成物 Active JP7818405B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025133519A JP2025172264A (ja) 2019-06-18 2025-08-08 炎症性状態を処置するための方法および組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962862977P 2019-06-18 2019-06-18
US62/862,977 2019-06-18
PCT/US2020/038036 WO2020257221A1 (en) 2019-06-18 2020-06-17 Methods and compositions for treating inflammatory conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025133519A Division JP2025172264A (ja) 2019-06-18 2025-08-08 炎症性状態を処置するための方法および組成物

Publications (4)

Publication Number Publication Date
JP2022536797A JP2022536797A (ja) 2022-08-18
JPWO2020257221A5 true JPWO2020257221A5 (https=) 2023-11-30
JP2022536797A5 JP2022536797A5 (https=) 2023-11-30
JP7818405B2 JP7818405B2 (ja) 2026-02-20

Family

ID=74040112

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021574932A Active JP7818405B2 (ja) 2019-06-18 2020-06-17 炎症性状態を処置するための方法および組成物
JP2025133519A Withdrawn JP2025172264A (ja) 2019-06-18 2025-08-08 炎症性状態を処置するための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025133519A Withdrawn JP2025172264A (ja) 2019-06-18 2025-08-08 炎症性状態を処置するための方法および組成物

Country Status (6)

Country Link
US (1) US20220313780A1 (https=)
EP (2) EP4461303A3 (https=)
JP (2) JP7818405B2 (https=)
CN (1) CN114258317B (https=)
AU (1) AU2020295989A1 (https=)
WO (1) WO2020257221A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120518705A (zh) * 2025-07-23 2025-08-22 中国海洋大学 一种多肽类化合物及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965343A (en) 1988-01-28 1990-10-23 Hoffmann-La Roche Inc. Method of peptide synthesis
US5849954A (en) 1996-01-18 1998-12-15 Research Corporation Technologies, Inc. Method of peptide synthesis
US5892014A (en) * 1996-10-30 1999-04-06 The Regents Of The University Of California DNA encoding a protease-activated receptor 3
CN1308671A (zh) * 1998-05-05 2001-08-15 科里克萨公司 髓磷脂碱性蛋白肽及其应用
ATE281472T1 (de) 1999-08-02 2004-11-15 Synt Em Sa Berechnungsmethoden zur herstellung von molekularen mimetika
US7271256B2 (en) 2000-02-04 2007-09-18 New England Biolabs, Inc. Method for producing circular or multimeric protein species in vivo or in vitro and related methods
JP4798921B2 (ja) * 2000-03-06 2011-10-19 バイオシーク インコーポレーティッド 機能相同性スクリーニング
US7696168B2 (en) * 2000-04-21 2010-04-13 Tufts Medical Center, Inc. G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same
FR2841559A1 (fr) * 2002-06-28 2004-01-02 Pfizer Recepteurs par modifies, preparation et utilisations
GB0224013D0 (en) * 2002-10-15 2002-11-27 Oxford Glycosciences Uk Ltd A protein involved in therapy
WO2004056309A2 (en) * 2002-12-05 2004-07-08 Socratech L.L.C. Neuroprotective activity of activated protein c is independent of its anticoagulant activity
AU2006242449A1 (en) 2005-04-29 2006-11-09 (Osi) Eyetech, Inc. VEGF variants
US20080090760A2 (en) 2005-12-09 2008-04-17 Todd Hembrough Compositions and Methods for Inhibiting Cellular Proliferation
CN101801462A (zh) * 2007-07-13 2010-08-11 健泰科生物技术公司 用于癌症、炎性病症和自身免疫性病症的治疗和诊断
WO2013070256A2 (en) * 2011-11-07 2013-05-16 The Scripps Research Institute Protease activated receptor-1 (par1) derived cytoprotective polypeptides and related methods
CN104470943B (zh) * 2012-07-03 2017-07-14 一洋药品株式会社 新肽及其用途
WO2017173346A1 (en) * 2016-04-01 2017-10-05 Arizona Board Of Regents On Behalf Of The University Of Arizona Par3 mimetic peptides and uses thereof
CA3075833C (en) * 2017-09-18 2024-06-11 BH Biotech Pty Ltd Composition comprising withania extract, omega-3 fatty acids and natural product extracts and uses thereof

Similar Documents

Publication Publication Date Title
US5770191A (en) Active C-terminal peptides of interferon--gamma and their use
JP2010540654A5 (https=)
CN102665754A (zh) 衍生自il-2的免疫调节多肽及其在治疗癌症和慢性感染中的用途
EP0230574A2 (en) Pharmaceutical compositions against infections caused by LAV/HTLV III virus and the use thereof
JP2021514354A5 (https=)
US20120213790A1 (en) Methods of treatment using il-16 antagonist peptides
US6664374B1 (en) Polypeptides comprising IL-6 ligand-binding receptor domains
KR101620341B1 (ko) 염증성장질환 및 1형 당뇨병치료를 위한 ａｐｌ 펩티드의 사용
JPWO2020257221A5 (https=)
US7323444B2 (en) Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis
JP2007500693A (ja) 移植片拒絶反応を予防するための合成ペプチドコポリマーを含む併用療法
RU2126266C1 (ru) Способ ингибирования ретровирусной инфекции (варианты), ингибитор протеазы, кодирующая его нуклеиновая кислота и способ рекомбинантного продуцирования серинового ингибитора
US7494975B2 (en) Anti-HIV composition, production method thereof and medicament
WO1995025537A1 (en) Drug for relieving side effects caused by immunosuppressants
CN110139659B (zh) 用于治疗干燥综合征的肽
US20260028397A1 (en) Methods of treating ankylosing spondylitis
AU2581197A (en) Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity
WO2004003007A1 (fr) Peptides se liant a des cellules non lymphocytaires, et utilisations correspondantes
WO2019037482A1 (zh) 具有血栓溶解活性的多肽
AU763900B2 (en) Treatment of HIV-infection by interfering with host cell cyclophilin receptor activity
HK40012327A (en) Peptides for treating sjogren's syndrome
Mattos et al. Interleukin-10 steers the hepatic stellate cell-macrophage axis during liver fibrogenesis